scholarly article | Q13442814 |
P2093 | author name string | Chen MC | |
Chen YS | |||
Chen CL | |||
Chou FF | |||
Sheen-Chen SM | |||
P433 | issue | 15 | |
P921 | main subject | cholangiocarcinoma | Q124292 |
P304 | page(s) | 760-765 | |
P577 | publication date | 1997-05-01 | |
P1433 | published in | Hepato-Gastroenterology | Q15752074 |
P1476 | title | Surgical treatment of cholangiocarcinoma. | |
P478 | volume | 44 |
Q37166422 | Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis |
Q33593250 | Adjuvant therapy in biliary tract and gall bladder carcinomas: a review |
Q35787306 | Apoptosis and tumorigenesis in human cholangiocarcinoma cells. Involvement of Fas/APO-1 (CD95) and calmodulin |
Q34633986 | Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma |
Q36076490 | Diagnostic and surgical therapeutic features of extrahepatic bile duct carcinoma without jaundice |
Q45204281 | Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period |
Q47574361 | Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma |
Q35674607 | Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management |
Q36551110 | Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma |
Q55286813 | Role of palliative radiotherapy in unresectable intrahepatic cholangiocarcinoma: population-based analysis with propensity score matching. |
Q82815094 | Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma |
Q46709990 | Surgical therapy of intrahepatic cholangiocellular carcinoma |
Q37116796 | The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience. |
Q37337144 | The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome |
Q35244211 | The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? |
Q26781036 | Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review |
Q35046078 | Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis |
Q37151082 | Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study |
Search more.